Manufacturer of Controlled Substances; Notice of Application, 22844 [2010-10116]
Download as PDF
<![CDATA[
22844
Federal Register / Vol. 75, No. 83 / Friday, April 30, 2010 / Notices
(2) Title of the Form/Collection: 2009
Census of Publicly Funded Forensic
Crime Laboratories.
(3) Agency form number, if any, and
the applicable component of the
Department of Justice sponsoring the
collection: The form number is CFCL–1,
Bureau of Justice Statistics, Office of
Justice Programs, U.S. Department of
Justice.
(4) Affected public who will be asked
or required to respond, as well as a brief
abstract: Respondents will represent
Federal, State, and local governments.
This information collection is a census
of public crime laboratories that perform
forensic analyses on criminal evidence.
The information will provide statistics
on laboratories’ capacity to analyze
forensic crime evidence, the number,
types, and sources of evidence received
per year, and the number, types, and
cost of analyses completed.
(5) An estimate of the total number of
respondents and the amount of time
estimated for an average respondent to
respond: It is estimated that 405
respondents will complete a 4.1 hour
form.
(6) An estimate of the total public
burden (in hours) associated with the
collection: The total hour burden to
complete the data collection is 1,660.5
annual burden hours.
If additional information is required
contact: Lynn Bryant, Department
Clearance Officer, United States
Department of Justice, Information
Management and Security Staff, Justice
Management Division, Suite 1600,
Patrick Henry Building, 601 D Street,
NW., Washington, DC 20530.
Drug
Schedule
Raw Opium (9600) .......................
Poppy Straw (9650) .....................
Concentrate of Poppy Straw
(9670).
II
II
II
The company plans to import the
listed controlled substances to
manufacture bulk controlled substance
intermediates for sale to its customers.
As explained in the Correction to
Notice of Application pertaining to
Rhodes Technologies, 72 FR 3417
(2007), comments and requests for
hearings on applications to import
narcotic raw material are not
appropriate.
As noted in a previous notice
published in the Federal Register on
September 23, 1975, (40 FR 43745), all
applicants for registration to import a
basic class of any controlled substance
in schedule I or II are, and will continue
to be, required to demonstrate to the
Deputy Assistant Administrator, Office
of Diversion Control, Drug Enforcement
Administration, that the requirements
for such registration pursuant to 21
U.S.C. 958(a); 21 U.S.C. 823(a); and 21
CFR 1301.34(b), (c), (d), (e), and (f) are
satisfied.
Dated: April 26, 2010.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. 2010–10115 Filed 4–29–10; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Dated: April 27, 2010.
Lynn Bryant,
Department Clearance Officer, PRA, United
States Department of Justice.
Drug Enforcement Administration
[FR Doc. 2010–10142 Filed 4–29–10; 8:45 am]
Pursuant to § 1301.33(a) of Title 21 of
the Code of Federal Regulations (CFR),
this is notice that on March 16, 2010,
Lonza Riverside, 900 River Road,
Conshohocken, Pennsylvania 19428,
made application by renewal to the
Drug Enforcement Administration
(DEA) to be registered as a bulk
manufacturer of the basic classes of
controlled substances listed in
schedules I and II:
BILLING CODE 4410–18–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
wwoods2 on DSK1DXX6B1PROD with NOTICES_PART 1
Importer of Controlled Substances;
Notice of Application
This is notice that on March 15, 2010,
Penick Corporation, 33 Industrial Park
Road, Pennsville, New Jersey 08070,
made application by renewal to the
Drug Enforcement Administration
(DEA) for registration as an importer of
the basic classes of controlled
substances listed in schedule II.
Drug
Schedule
Coca Leaves (9040) .....................
VerDate Mar<15>2010
13:41 Apr 29, 2010
II
Jkt 220001
Manufacturer of Controlled
Substances; Notice of Application
Drug
Schedule
Gamma
hydroxybutyric
acid
(2010).
Amphetamine (1100) ....................
Methylphenidate (1724) ................
I
II
II
The company plans to manufacture
bulk active pharmaceutical ingredients
(APIs) for distribution to its customers.
PO 00000
Frm 00109
Fmt 4703
Sfmt 4703
Any other such applicant, and any
person who is presently registered with
DEA to manufacture such substances,
may file comments or objections to the
issuance of the proposed registration
pursuant to 21 CFR 1301.33(a).
Any such written comments or
objections should be addressed, in
quintuplicate, to the Drug Enforcement
Administration, Office of Diversion
Control, Federal Register Representative
(ODL), 8701 Morrissette Drive,
Springfield, Virginia 22152; and must be
filed no later than June 29, 2010.
Dated: April 26, 2010.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. 2010–10116 Filed 4–29–10; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF LABOR
Occupational Safety and Health
Administration
[Docket No. OSHA–2010–0008]
Construction Fall Protection Systems
Criteria and Practices and Training
Requirements; Extension of the Office
of Management and Budget’s (OMB)
Approval of Information Collection
(Paperwork) Requirements
AGENCY: Occupational Safety and Health
Administration (OSHA), Labor.
ACTION: Request for public comment.
SUMMARY: OSHA solicits public
comments concerning its proposal to
extend OMB approval of the
information collection requirements
contained in the construction standards
on Fall Protection Systems Criteria and
Practices (29 CFR 1926.502) and
Training Requirements (29 CFR
1926.503).
DATES: Comments must be submitted
(postmarked, sent, or received) by June
29, 2010.
ADDRESSES: Electronically: You may
submit comments and attachments
electronically at https://
www.regulations.gov, which is the
Federal eRulemaking Portal. Follow the
instructions online for submitting
comments.
Facsimile: If your comments,
including attachments, are not longer
than 10 pages, you may fax them to the
OSHA Docket Office at (202) 693–1648.
Mail, hand delivery, express mail,
messenger, or courier service: When
using this method, you must submit
three copies of your comments and
attachments to the OSHA Docket Office,
E:\FR\FM\30APN1.SGM
30APN1
]]>Agencies
[Federal Register Volume 75, Number 83 (Friday, April 30, 2010)]
[Notices]
[Page 22844]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-10116]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Application
Pursuant to Sec. 1301.33(a) of Title 21 of the Code of Federal
Regulations (CFR), this is notice that on March 16, 2010, Lonza
Riverside, 900 River Road, Conshohocken, Pennsylvania 19428, made
application by renewal to the Drug Enforcement Administration (DEA) to
be registered as a bulk manufacturer of the basic classes of controlled
substances listed in schedules I and II:
------------------------------------------------------------------------
Drug Schedule
------------------------------------------------------------------------
Gamma hydroxybutyric acid (2010)........... I
Amphetamine (1100)......................... II
Methylphenidate (1724)..................... II
------------------------------------------------------------------------
The company plans to manufacture bulk active pharmaceutical
ingredients (APIs) for distribution to its customers.
Any other such applicant, and any person who is presently
registered with DEA to manufacture such substances, may file comments
or objections to the issuance of the proposed registration pursuant to
21 CFR 1301.33(a).
Any such written comments or objections should be addressed, in
quintuplicate, to the Drug Enforcement Administration, Office of
Diversion Control, Federal Register Representative (ODL), 8701
Morrissette Drive, Springfield, Virginia 22152; and must be filed no
later than June 29, 2010.
Dated: April 26, 2010.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. 2010-10116 Filed 4-29-10; 8:45 am]
BILLING CODE 4410-09-P
